Skip to content

VASCU-GUARD Peripheral Vascular Patch VG0106NRecalls & reported problems

Synovis Life Technologies, Inc. · VASCU-GUARD Peripheral Vascular Patch is prepared from bovine pericardium which is cross-linked with glutaraldehyde. The pericardium is procured from cattle originating in the United States. VASCU-GUARD Peripheral Vascular Patch is chemically sterilized using ethanol and propylene oxide. VASCU-GUARD Peripheral Vascular Patch has been treated with 1 molar sodium hydroxide for a minimum of 60 minutes at 20 - 25 C. VASCU-GUARD Peripheral Vascular Patch is packaged in a container filled with sterile, non-pyrogenic water containing propylene oxide. The contents of the unopened, undamaged container are sterile. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00085412530871), received between Jul 18, 2023 and Jul 18, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Aneurysm1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 18, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT A LEFT POPLITEAL ARTERIAL SURGERY IN WHICH VASCU-GUARD PATCHES WERE USED. THIS WAS FURTHER SPECIFIED AS ¿A LONGITUDINAL INCISION WAS MADE, AND THE PATCH WAS INSERTED¿ AND ¿THERE WAS NO REINFORCEMENT¿. APPROXIMATELY FIVE YEARS AND THREE MONTHS LATER, AN ANEURYSM WAS DIAGNOSED AND SUBSEQUENTLY RESECTED. IT WAS REPORTED THE ANEURYSM ORIGINATED FROM THE CENTER OF THE DEVICE. ADDITIONAL TREATMENT OR MEDICAL INTERVENTIONS WERE NOT REPORTED. AT THE TIME OF THIS REPORT, THE PATIENT OUTCOME WAS NOT REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE.

    Patient problems: Aneurysm

    MAUDE report 17342274 ↗

Other PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE devices

All PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page